Core Points - The company announced that its wholly-owned subsidiary, Guizhou Anjia Mining Co., Ltd., has suspended production due to a safety incident [1] - Anjia Mining has received approval from local authorities to resume production starting August 16, following the submission of the necessary documentation [1] - The suspension lasted for 32 days and is expected to result in a reduction of approximately 30,000 tons in coal production [1] - The specific impact of this suspension on the company's financial performance will be disclosed in future financial reports [1]

Core Viewpoint - The company announced a temporary production halt due to a safety incident at its wholly-owned subsidiary, Guizhou Anjia Mining Co., Ltd, which is set to resume operations after addressing safety issues [1] Group 1: Incident and Response - On July 15, 2025, Guizhou Anjia Mining experienced a safety accident leading to a production suspension [1] - During the suspension, the company focused on rectifying identified issues and hazards in the coal mine [1] Group 2: Resumption of Operations - On August 14, 2025, the local authorities approved the resumption of operations based on compliance with safety production requirements [1] - Production is scheduled to restart on August 16, 2025, following the approval from the Tongzi County Industrial Energy and Science Technology Bureau and the Tongzi County People's Government [1]

安佳矿业主要从事煤炭开采、销售，负责运营贵州安佳矿业有限公司桐梓县花秋镇花秋二矿（以下简 称"花秋二矿"），花秋二矿核定产能60万吨/年。安佳矿业2024年末总资产99,505.86万元，占公司经审 计合并报表总资产的20.58%，2024年度合并抵消前实现营业收入2,446.93万元，占公司经审计合并报表 营业收入的1.03%；2025年第一季度末总资产101,880.56万元，占公司合并报表总资产（未经审计）的 21.6%，2025年第一季度合并抵消前实现营业收入207.82万元，占公司合并报表营业收入（未经审计） 的0.37%。安佳矿业本次因安全事故共停产32天，预计影响煤炭生产量减少约3万吨，本次停产对公司 经营业绩所产生的具体影响以财务报告披露数据为准。 格隆汇8月15日丨赤天化(600227.SH)公布，停产期间，公司认真做好煤矿停产整顿工作，对所查问题和 隐患进行了整改。2025年8月14日，根据《贵州省煤矿安全生产基本要求》的规定，桐梓县工业能源和 科学技术局、桐梓县人民政府审批同意安佳矿业提交的《桐梓县2025年煤矿复工复产审批表》，安佳矿 业从8月16日起恢复生产。 ...

赤天化公告，2025年7月15日，贵州赤天化股份有限公司全资子公司安佳矿业因安全事故停产。停产期 间，公司对问题和隐患进行整改。8月14日，桐梓县相关部门审批同意其复工复产申请，安佳矿业于8月 16日起恢复生产。安佳矿业运营花秋二矿，核定产能60万吨/年。2024年末总资产占公司经审计合并报 表总资产的20.58%，2025年一季度末占比21.6%。此次停产32天，预计影响煤炭生产量约3万吨，具体 业绩影响以财务报告为准，公司提醒投资者注意风险。 ...

Core Viewpoint - The announcement details the progress of guarantees provided by Guizhou Chitianhua Co., Ltd. for its wholly-owned subsidiaries, Guizhou Daqin Tumor Hospital Co., Ltd. and Guizhou Chitianhua Tongzi Chemical Co., Ltd., including specific amounts and terms of the guarantees [1][2][3]. Summary by Sections Guarantee Overview - The company has approved a total guarantee limit of up to 1.8 billion RMB for its subsidiaries in 2025, which includes the renewal of existing guarantees [2][3]. - The company has provided a guarantee of 24.46 million RMB to Daqin Hospital and 70 million RMB to Tongzi Chemical as of July 31, 2025 [1][2]. Details of the Guaranteed Entities - Guizhou Daqin Tumor Hospital has total assets of 1.16 billion RMB and liabilities of 807.86 million RMB as of March 31, 2025, with a net loss of 2.98 million RMB in Q1 2025 [5]. - Guizhou Chitianhua Tongzi Chemical has total assets of 272.82 million RMB and liabilities of 117.26 million RMB as of March 31, 2025, with a net profit of 1.38 million RMB in Q1 2025 [7]. Guarantee Agreements - The company has entered into a guarantee agreement with China Agricultural Development Bank for Daqin Hospital, covering a principal amount of 650 million RMB [9][10]. - A separate guarantee agreement with Guizhou Bank for Tongzi Chemical covers a principal amount of 840 million RMB [11][12]. Necessity and Reasonableness of Guarantees - The guarantees are deemed necessary for supporting the subsidiaries' project construction and daily operations, with the company maintaining effective control over the subsidiaries' operational risks [14]. - The total external guarantees amount to 1.15 billion RMB, representing 45.34% of the company's latest audited net assets [15].

证券日报网讯7月31日晚间，赤天化（600227）发布公告称，截至本公告日，公司及公司控股子公司对 外担保总额为115，374.44万元，占公司最近一期经审计归属于上市公司股东净资产的比例为45.34%， 对外担保均为公司为报表合并范围内的子公司提供的担保。公司及子公司无逾期担保的情形。 ...

证券代码：600227 证券简称：赤天化 编号：2025-051 贵州赤天化股份有限公司 关于提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●被担保人名称及是否为上市公司关联人：被担保人贵州大秦肿 瘤医院有限公司（以下简称"大秦医院"）和贵州赤天化桐梓化工有 限公司（以下简称"桐梓化工"）系公司的全资子公司。 ●本次担保金额及已实际为其提供的担保余额：①2025年7月， 公司对大秦医院增加担保金额为2,446万元，截止至2025年7月31日， 公司累计为大秦医院提供担保余额为63,294.44万元；②2025年7月， 公司对桐梓化工增加担保金额为7,000万元，截止至2025年7月31日， 公司累计为桐梓化工提供担保余额为52,080万元；2025年7月，公司 提供担保的子公司归还借款金额11,100万元，截止至2025年7月31日， 公司及公司控股子公司对外担保总额为115,374.44万元，对外担保均 为公司为报表合并范围内的子公司提供的担保。 ●本次担保是否有反担保：否 ●对外担保逾 ...

关于全资子公司安佳矿业停产的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、基本情况 贵州赤天化股份有限公司（以下简称"公司"）全资子公司贵州 安佳矿业有限公司（以下简称"安佳矿业"）于 2025 年 7 月 15 日凌 晨 2 时 30 分左右发生一起事故，致一人受伤，后经抢救无效死亡。 初步查明是由于安佳矿业煤仓发生溃水，水流从主斜井上部向下冲刷， 将 1 名主井作业人员冲倒并随水流滚落至井底。具体原因有待进一步 调查。按照有关规定，矿井在此期间停止除通风、排水、瓦斯检查外 的一切作业活动。 证券代码:600227 证券简称:赤 天 化 编号:2025-050 贵州赤天化股份有限公司 安佳矿业主要从事煤炭开采、销售，负责运营贵州安佳矿业有限 公司桐梓县花秋镇花秋二矿（以下简称"花秋二矿"），花秋二矿核 定产能 60 万吨/年。安佳矿业 2024 年末总资产 99,505.86 万元，占 公司经审计合并报表总资产的 20.58%，2024 年度合并抵消前实现营 业收入 2,446.93 万元，占公司经审计合并报表营 ...

Core Viewpoint - Guizhou Chitianhua Co., Ltd. expects to report a net loss for the first half of 2025, with projected losses ranging from 35 million to 52 million yuan, indicating a continuation of losses compared to the same period last year [1][2]. Group 1: Performance Forecast - The company anticipates a net profit attributable to shareholders of the parent company for the first half of 2025 to be between -35 million and -52 million yuan [1]. - The projected net profit after deducting non-recurring gains and losses is expected to be between -36 million and -53 million yuan [1]. Group 2: Previous Year Performance - In the same period last year, the total profit was -36.3042 million yuan, with a net profit attributable to shareholders of the parent company at -36.7430 million yuan [2]. - The net profit after deducting non-recurring gains and losses was -50.1754 million yuan, with an earnings per share of -0.0217 yuan [2]. Group 3: Reasons for Expected Loss - The main business is affected by high fixed costs such as labor, depreciation, and financial expenses, leading to continued losses in the hospital business [2]. - The coal mining segment is facing high production costs due to low overall coal output and a decline in coal market prices in 2025, contributing to losses [2].

[Current Period Performance Forecast](index=1&type=section&id=一%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E6%83%85%E5%86%B5) The company anticipates continued losses in H1 2025, with net profit attributable to shareholders estimated between **RMB -35 million and -52 million**, and non-recurring net profit between **RMB -36 million and -53 million** 2025 Semi-Annual Performance Forecast | Performance Indicator (2025 Semi-Annual Forecast) | Amount Range (RMB) | | :------------------------------------------------ | :------------------------------- | | Net Profit Attributable to Parent Company Shareholders | -35 Million RMB to -52 Million RMB | | Net Profit Attributable to Parent Company Shareholders After Deducting Non-Recurring Gains and Losses | -36 Million RMB to -53 Million RMB | - The company explicitly states that the performance forecast data for this period has not been audited by a certified public accountant[3](index=3&type=chunk) [Operating Performance and Financial Status for the Same Period Last Year](index=1&type=section&id=二%E3%80%81%E4%B8%8A%E5%B9%B4%E5%90%8C%E6%9C%9F%E7%BB%8F%E8%90%A5%E4%B8%9A%E7%BB%A9%E5%92%8C%E8%B4%A2%E5%8A%A1%E7%8A%B6%E5%86%B5) In H1 2024, the company reported a net loss attributable to parent company shareholders of **RMB 36.743 million** and a non-recurring net loss of **RMB 50.1754 million**, with earnings per share at **RMB -0.0217** 2024 Semi-Annual Operating Performance | Performance Indicator (2024 Semi-Annual) | Amount/Value (RMB) | | :--------------------------------------- | :----------------- | | Total Profit | -36.3042 Million RMB | | Net Profit Attributable to Parent Company Shareholders | -36.7430 Million RMB | | Net Profit Attributable to Parent Company Shareholders After Deducting Non-Recurring Gains and Losses | -50.1754 Million RMB | | Earnings Per Share | -0.0217 RMB | [Primary Reasons for Current Period's Estimated Loss](index=2&type=section&id=三%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E4%BA%8F%E7%9A%84%E4%B8%BB%E8%A6%81%E5%8E%9F%E5%9B%A0) The estimated loss primarily stems from core business challenges, including high fixed costs in hospital operations during market cultivation and high production costs in coal mining due to limited output and declining market prices, partially offset by positive non-operating gains [Impact of Core Business Operations](index=2&type=section&id=%EF%BC%88%E4%B8%80%EF%BC%89%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E5%BD%B1%E5%93%8D) Core business losses are driven by hospital operations facing high fixed costs despite revenue growth, and coal mining experiencing high production costs due to limited output and declining market prices - Hospital business remains in its market and reputation cultivation phase, with increasing operating revenue insufficient to cover high fixed costs, including labor, depreciation, amortization, and financial expenses, leading to continuous losses[6](index=6&type=chunk) - Coal mining business, despite increased production and sales, faces high production costs due to most mining faces being in the excavation layout stage, resulting in low overall raw coal output; declining coal market prices in 2025 further negatively impacted the business, leading to losses[6](index=6&type=chunk) [Impact of Non-Operating Gains and Losses](index=2&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%E9%9D%9E%E7%BB%8F%E8%90%A5%E6%80%A7%E6%8D%9F%E7%9B%8A%E7%9A%84%E5%BD%B1%E5%93%8D) Non-operating gains and losses positively impacted net profit by approximately **RMB 1.1 million** in H1 2025, primarily from government subsidies recognized in current period profit or loss - Non-operating gains and losses had a positive impact of approximately **RMB 1.1 million** on net profit in the first half of 2025, primarily from government subsidies recognized in current period profit or loss[6](index=6&type=chunk) [Risk Warning](index=2&type=section&id=四%E3%80%81%E9%A3%8E%E9%99%A9%E6%8F%90%E7%A4%BA) The company emphasizes that this performance forecast is a preliminary, unaudited financial department calculation, with no significant uncertainties identified that would impact its accuracy - The company states that this performance forecast is a preliminary calculation by the finance department and has not been audited by a certified public accountant[7](index=7&type=chunk) [Other Explanatory Matters](index=2&type=section&id=五%E3%80%81%E5%85%B6%E4%BB%96%E8%AF%B4%E6%98%8E%E4%BA%8B%E9%A1%B9) Investors are reminded that the disclosed data is preliminary, and final accurate financial data will be based on the officially released 2025 semi-annual report, with investment risks noted - The final accurate financial data will be based on the company's officially disclosed 2025 semi-annual report; investors are advised to be aware of investment risks[8](index=8&type=chunk)